Product Information

CAPECITABINE 500 MG TABLET is a generic product labeled by Cipla USA Inc., priced at $0.4679 per EA under NDC 69097094808. Its NADAC has been published 355 times since Nov 21, 2018.

FDA first approved this application on Jul 2, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

CAPECITABINE 500 MG TABLET

Capecitabine
$0.4679per EA

Strength

500 mg/1

Manufacturer

Cipla USA Inc.

NDC

69097094808

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

CAPECITABINE

Approval Type

Generic (ANDA)

FDA Application

ANDA209365

FDA Approved

7/2/2018

TE Code

AB

On Market Since

7/1/2023

Pharmacological Classes

Nucleic Acid Synthesis Inhibitors
Nucleoside Metabolic Inhibitor

Price Statistics

The NADAC for CAPECITABINE 500 MG TABLET has been published 355 times since Nov 21, 2018, and over the history we have for it it has declined 89.1%. The table below summarizes its recorded NADAC range and movement.

Current price$0.4679 per EA
All-time high$4.2997 (Jan 16, 2019)
All-time low$0.4342 (Nov 20, 2024)
52-week high$0.5336
52-week low$0.4679
Median price$0.5863
Average price$1.2979
Largest weekly change-67.4% (Dec 23, 2020)
Weeks tracked355
Tracking sinceNov 21, 2018

Price History

1W

-1.2%

1M

-1.2%

3M

-5.7%

6M

-9.5%

1Y

-4.4%

3Y

-12.5%

5Y

-20.2%

All

-89.1%

Generic Alternatives

The matcher finds 11 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 1% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of CAPECITABINE 500 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for CAPECITABINE 500 MG TABLET, manufactured by Cipla USA Inc., is $0.4679 per EA (NDC 69097094808), effective Aug 19, 2026.

How has the price of CAPECITABINE 500 MG TABLET changed over time?

Over the history we have for it, the NADAC for CAPECITABINE 500 MG TABLET has declined 89.1%. It has been tracked across 355 weekly CMS publications since Nov 21, 2018.

What are the highest and lowest recorded NADAC prices for CAPECITABINE 500 MG TABLET?

Since Nov 21, 2018, the NADAC for CAPECITABINE 500 MG TABLET has ranged from a low of $0.4342 (Nov 20, 2024) to a high of $4.2997 (Jan 16, 2019), with a median of $0.5863 per EA.

Are there cheaper alternatives to CAPECITABINE 500 MG TABLET?

Yes. 11 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CAPECITABINE 500 MG TABLET, is $0.4615 per EA — about 1% below CAPECITABINE 500 MG TABLET.

Who manufactures CAPECITABINE 500 MG TABLET?

CAPECITABINE 500 MG TABLET (NDC 69097094808) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.